Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Sell
32
CTOR Quote, Financials, Valuation and Earnings
Last price:
$0.90
Seasonality move
:
-39.85%
Day range:
$0.83 - $0.91
52-week range:
$0.55 - $49.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.81x
Volume:
24K
Avg. volume:
57.3K
1-year change:
-92.08%
Market cap:
$64.4M
Revenue:
--
EPS (TTM):
-$0.33
Earnings Data
Next earnings date for CTOR
Dec 26
2025
Most recent earnings per share
-$0.11
Missed by $0.11
(May 14/2025)
Consensus Estimate
--
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CTOR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/08/2025 | Q2 | -- | -- | -- | -- | -- |
| 05/14/2025 | Q1 | $5.7M | -- | -$0.11 | -- | -- |
| 02/14/2025 | Q4 | -- | -- | -$0.09 | -- | -- |
| 12/27/2024 | Q3 | -- | -- | -- | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.07 | -- | -- |
Citius Oncology Earnings Questions
-
How Much did Citius Oncology Generate in Revenue Last Quarter?
Citius Oncology reported -- worth of top line sales in its most recent quarter.
-
Did Citius Oncology Beat Earnings Last Quarter?
Citius Oncology announced earnings per share of -$0.11 which represents a miss of analyst forecast a -- per share.
-
Is Citius Oncology Profitable?
Citius Oncology reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Citius Oncology EPS Next Year?
Citius Oncology's earnings are forecast to grow from -$0.31 per share to -- per share next year representing an increase of --.
-
When is Citius Oncology's Earnings Date?
Citius Oncology's next earnings date is December 26, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
